Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Angiodynamics (ANGO) over the last 16 years, with Q4 2025 value amounting to -$48000.0.

  • Angiodynamics' Deferred Taxes rose 8072.29% to -$48000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was -$520000.0, marking a year-over-year decrease of 11411.51%. This contributed to the annual value of $40.0 million for FY2016, which is 88046.07% up from last year.
  • Per Angiodynamics' latest filing, its Deferred Taxes stood at -$48000.0 for Q4 2025, which was up 8072.29% from -$16000.0 recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' Deferred Taxes ranged from a high of $16.4 million in Q4 2023 and a low of -$12.1 million during Q1 2024
  • Over the past 5 years, Angiodynamics' median Deferred Taxes value was -$569000.0 (recorded in 2021), while the average stood at -$900600.0.
  • Per our database at Business Quant, Angiodynamics' Deferred Taxes soared by 274822.01% in 2023 and then plummeted by 522775.33% in 2024.
  • Quarter analysis of 5 years shows Angiodynamics' Deferred Taxes stood at -$569000.0 in 2021, then decreased by 8.61% to -$618000.0 in 2022, then skyrocketed by 2748.22% to $16.4 million in 2023, then tumbled by 101.52% to -$249000.0 in 2024, then skyrocketed by 80.72% to -$48000.0 in 2025.
  • Its last three reported values are -$48000.0 in Q4 2025, -$16000.0 for Q3 2025, and -$207000.0 during Q1 2025.